Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Apr 1;61(4):2300208.
doi: 10.1183/13993003.00208-2023. Print 2023 Apr.

Design considerations and implications of findings on progressive pulmonary fibrosis from the prospective Canadian Registry for Pulmonary Fibrosis

Christopher J Ryerson  1   2 , Nathan Hambly  3 , Martin Kolb  3
Affiliations
Free article
Comment

Design considerations and implications of findings on progressive pulmonary fibrosis from the prospective Canadian Registry for Pulmonary Fibrosis

Christopher J Ryerson et al. Eur Respir J. .
Free article
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: C.J. Ryerson reports support for the present manuscript from Boehringer Ingelheim; grants from Boehringer Ingelheim and Hoffmann-La Roche; consulting fees from Boehringer Ingelheim, Hoffmann-La Roche, AstraZeneca, Veracyte, Ensho and Pliant Therapeutics; lecture honoraria from Boehringer Ingelheim, Hoffmann-La Roche and Cipla Ltd; travel support from Cipla Ltd and Boehringer Ingelheim; outside the submitted work. Conflict of interest: N. Hambly reports grants from Boehringer Ingelheim and Janssen; lecture honoraria and travel support from Boehringer Ingelheim, Janssen and Roche; outside the submitted work. Conflict of interest: M. Kolb reports support for the present manuscript from Boehringer Ingelheim; grants from Boehringer Ingelheim, Pieris and Roche; consulting fees from Boehringer Ingelheim, Roche, Horizon, Cipla, Abbvie, Bellerophon, Algernon, CSL Behring, United Therapeutics, LabCorp and ShouTi; lecture honoraria from Roche, Novartis, Boehringer Ingelheim; payment for expert testimony from Roche; advisory board participation from United Therapeutics and LabCorp; and reports an allowance as Chief Editor ERJ.

Comment on

LinkOut - more resources